Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Dimethyl 2-oxoglutarate, a key intermediate in the Krebs cycle, is an essential nitrogen transporter in biological metabolic pathways. It is characterized by its slight yellow liquid appearance and has been studied for its electrochemical behavior using various voltammetry techniques.

13192-04-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 13192-04-6 Structure
  • Basic information

    1. Product Name: Dimethyl 2-oxoglutarate
    2. Synonyms: DIMETHYL 2-OXOGLUTARATE;DIMETHYL 2-KETOGLUTARATE;DIMETHYL OXOGLUTARATE;ALPHA-Ketoglutaric acid dimethyl ester;2-KETOGLUTARIC ACID DIMETHYL ESTER (ALPHA-) 95+%;α-Ketoglutaric acid dimethyl ester;Dimethyl 2-oxopentanedioate;Dimethyl α-ketoglutarate
    3. CAS NO:13192-04-6
    4. Molecular Formula: C7H10O5
    5. Molecular Weight: 174.15
    6. EINECS: N/A
    7. Product Categories: Amino Acids 13C, 2H, 15N;Amino Acids & Derivatives;Miscellaneous Reagents;C6 to C7;Carbonyl Compounds;Esters
    8. Mol File: 13192-04-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 90-95 °C0.4 mm Hg(lit.)
    3. Flash Point: >230 °F
    4. Appearance: /
    5. Density: 1.203 g/mL at 25 °C(lit.)
    6. Vapor Pressure: 0.023mmHg at 25°C
    7. Refractive Index: n20/D 1.439(lit.)
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: Dimethyl 2-oxoglutarate(CAS DataBase Reference)
    11. NIST Chemistry Reference: Dimethyl 2-oxoglutarate(13192-04-6)
    12. EPA Substance Registry System: Dimethyl 2-oxoglutarate(13192-04-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 13192-04-6(Hazardous Substances Data)

13192-04-6 Usage

Uses

Used in Chemical Synthesis:
Dimethyl 2-oxoglutarate is used as a synthetic building block for the creation of various chemical compounds. Its application in the synthesis of conformationally constrained PNA (peptide nucleic acid) monomers enables the binding of thymine in a triplex motif, which has potential implications in genetic research and drug development.
Additionally, Dimethyl 2-oxoglutarate is used in the synthesis of 4-aryl kainic acid analogs through a highly stereoselective Michael addition reaction with nitrostyrene. This process contributes to the development of novel compounds with potential applications in neuroscience and pharmaceuticals.
Used in Research and Development:
Dimethyl 2-oxoglutarate serves as an important compound for research purposes, particularly in the study of metabolic pathways and the Krebs cycle. Its electrochemical behavior has been investigated using techniques such as cyclic voltammetry, square wave voltammetry, and differential pulse voltammetry, providing valuable insights into its properties and potential applications in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 13192-04-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,1,9 and 2 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 13192-04:
(7*1)+(6*3)+(5*1)+(4*9)+(3*2)+(2*0)+(1*4)=76
76 % 10 = 6
So 13192-04-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H10O5/c1-11-6(9)4-3-5(8)7(10)12-2/h3-4H2,1-2H3

13192-04-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name Dimethyl 2-oxoglutarate

1.2 Other means of identification

Product number -
Other names 2-Oxoglutaric Acid Dimethyl Ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13192-04-6 SDS

13192-04-6Synthetic route

methanol
67-56-1

methanol

α-ketoglutaric acid
328-50-7

α-ketoglutaric acid

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
With boron trifluoride at 65℃; for 0.333333h;100%
With toluene-4-sulfonic acid In chloroform Heating;94%
With sulfuric acid for 2h; Heating;90%
α-ketoglutaric acid
328-50-7

α-ketoglutaric acid

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
In methanol; benzene for 0.5h; Ambient temperature;85%
methanol
67-56-1

methanol

α-ketoglutaric acid
328-50-7

α-ketoglutaric acid

A

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

B

2-Oxoglutarsaeure-1-methylester
92684-01-0

2-Oxoglutarsaeure-1-methylester

Conditions
ConditionsYield
With 2,2-dimethoxy-propane for 144h; Ambient temperature;A 81%
B 7%
α-ketoglutaric acid
328-50-7

α-ketoglutaric acid

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
In diethyl ether at 0℃; for 4h;76%
4-methoxycarbonylmethyl-5-(2-methoxyphenyl)isoxazolidine-2,3-dicarboxylic acid 2-(1-chloroethyl) ester 3-methyl ester

4-methoxycarbonylmethyl-5-(2-methoxyphenyl)isoxazolidine-2,3-dicarboxylic acid 2-(1-chloroethyl) ester 3-methyl ester

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
With pyridine In tetrahydrofuran; water at 60℃;28%
4-methoxycarbonylmethyl-5-phenylisoxazolidine-2,3-dicarboxylic acid 2-(1-chloroethyl) ester 3-methyl ester

4-methoxycarbonylmethyl-5-phenylisoxazolidine-2,3-dicarboxylic acid 2-(1-chloroethyl) ester 3-methyl ester

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
With pyridine In tetrahydrofuran; water at 60℃;22%
2,5-dimethoxy-2,5-dihydro-furan-2-carboxylic acid methyl ester
62435-72-7

2,5-dimethoxy-2,5-dihydro-furan-2-carboxylic acid methyl ester

A

4-oxobutanoic acid methyl ester
13865-19-5

4-oxobutanoic acid methyl ester

B

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
With hydrogenchloride at 90℃; Erwaermen des Reaktionsprodukts mit Schwefelsaeure enthaltendem Methanol.;
2-Diaethylamino-glutaconsaeure-dimethylester

2-Diaethylamino-glutaconsaeure-dimethylester

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
With hydrogenchloride
dimethyl cis-epoxymethylsuccinate

dimethyl cis-epoxymethylsuccinate

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
at 360℃;
dimethyl trans-epoxymethylsuccinate

dimethyl trans-epoxymethylsuccinate

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
at 360℃;
N-(1-Methoxy-5,5-dimethyl-3-oxocyclohex-1-yl)benzamid
41893-54-3

N-(1-Methoxy-5,5-dimethyl-3-oxocyclohex-1-yl)benzamid

A

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

B

benzamide
55-21-0

benzamide

Conditions
ConditionsYield
With hydrogenchloride; ozone 1.) methylenechlorid, -60 deg C; 2.) methanol, room temp, 90 min.; Yield given. Multistep reaction. Yields of byproduct given;
1,3-dicarbomethoxy-1-(trimethylsilyloxy)propene
55590-96-0

1,3-dicarbomethoxy-1-(trimethylsilyloxy)propene

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
With 1-methoxy-2-(2-nitrovinyl)benzene; tin(IV) chloride other reagents: boron trifluoride etherate/2-methoxy-β-nitrostyrene, benzaldehyde, benzaldehyde, benzaldehyde dimethyl acetal;
hydrogenchloride
7647-01-0

hydrogenchloride

2,5-dimethoxy-2,5-dihydro-furan-2-carboxylic acid methyl ester
62435-72-7

2,5-dimethoxy-2,5-dihydro-furan-2-carboxylic acid methyl ester

A

4-oxobutanoic acid methyl ester
13865-19-5

4-oxobutanoic acid methyl ester

B

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
Erwaermen des Reaktionsprodukts mit Methanol und wenig Schwefelsaeure;
N-(1-Methoxy-5,5-dimethyl-3-oxo-1-cyclohexen-1-yl)benzamid
41893-53-2

N-(1-Methoxy-5,5-dimethyl-3-oxo-1-cyclohexen-1-yl)benzamid

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 30 percent / H2 / Pd/C / methanol / 48 h
2: 1.) Ozon; 2.) HCl / 1.) methylenechlorid, -60 deg C; 2.) methanol, room temp, 90 min.
View Scheme
2-furoic acid methyl ester
611-13-2

2-furoic acid methyl ester

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sulfuric acid / Electrolysis
2: aqueous hydrochloric acid , 35 percent / 90 °C / Erwaermen des Reaktionsprodukts mit Schwefelsaeure enthaltendem Methanol.
View Scheme
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

3-bromo-2-oxopentane-1,5-dioic acid dimethyl ester
148728-48-7

3-bromo-2-oxopentane-1,5-dioic acid dimethyl ester

Conditions
ConditionsYield
With copper(ll) bromide In chloroform; ethyl acetate for 18h; Heating;100%
With copper(ll) bromide In chloroform; ethyl acetate at 20℃; Reflux;100%
With copper(ll) bromide In chloroform; ethyl acetate for 18h; Heating;90%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

methyl 6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxylate
89532-94-5

methyl 6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxylate

Conditions
ConditionsYield
With acetic acid; hydrazine In methanol at 70℃; for 18h;100%
With hydrazine hydrate; acetic acid In methanol at 70℃;100%
With acetic acid; hydrazine In methanol for 5h; Reflux; Inert atmosphere;100%
With acetic acid; hydrazine In methanol for 12h; Heating;92%
With acetic acid; hydrazine In methanol Heating;92%
tryptamine
61-54-1

tryptamine

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

methyl 2,3,5,6,11,11b-hexahydro-3-oxo-1H-indolizino<8,7-b>indole-11b-carboxylate
79888-13-4

methyl 2,3,5,6,11,11b-hexahydro-3-oxo-1H-indolizino<8,7-b>indole-11b-carboxylate

Conditions
ConditionsYield
With acetic acid for 4h; Reflux; Inert atmosphere;97%
With acetic acid at 120℃; for 3h; Pictet-Spengler reaction;86%
In benzene for 1.5h; Heating;58%
2-(5-methoxyindol-3-yl)ethylamine
608-07-1

2-(5-methoxyindol-3-yl)ethylamine

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

methyl 8-methoxy-2,3,5,6,11,11b-hexahydro-3-oxo-1H-indolizino<8,7-b>indole-11b-carboxylate
129968-05-4

methyl 8-methoxy-2,3,5,6,11,11b-hexahydro-3-oxo-1H-indolizino<8,7-b>indole-11b-carboxylate

Conditions
ConditionsYield
With acetic acid for 4h; Reflux; Inert atmosphere;97%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

propargyl bromide
106-96-7

propargyl bromide

dimethyl 2-H-hydroxy-2-<2-(propynyl)>pentanedioate
179815-16-8

dimethyl 2-H-hydroxy-2-<2-(propynyl)>pentanedioate

Conditions
ConditionsYield
With aluminium; mercury dichloride In tetrahydrofuran at -78℃; for 4h;95%
With aluminium; mercury dichloride 1.) 40 deg C, 2.) -78 deg C; Yield given. Multistep reaction;
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

3-(3-oxo-3,4-dihydro-quinoxalin-2-yl)-propionic acid methyl ester
21580-64-3

3-(3-oxo-3,4-dihydro-quinoxalin-2-yl)-propionic acid methyl ester

Conditions
ConditionsYield
In methanol94%
trimethylsilyl cyanide
7677-24-9

trimethylsilyl cyanide

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

dimethyl 2-cyano-2-(trimethylsilyl)oxyglutarate
96304-82-4

dimethyl 2-cyano-2-(trimethylsilyl)oxyglutarate

Conditions
ConditionsYield
for 19h; Ambient temperature;93%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

diisopropyl (E)-azodicarboxylate
2446-83-5

diisopropyl (E)-azodicarboxylate

3-isopropyl 2-methyl 5-isopropoxy-2-(3-methoxy-3-oxopropyl)-1,3,4-oxadiazole-2,3(2H)-dicarboxylate

3-isopropyl 2-methyl 5-isopropoxy-2-(3-methoxy-3-oxopropyl)-1,3,4-oxadiazole-2,3(2H)-dicarboxylate

Conditions
ConditionsYield
With triphenylphosphine In tetrahydrofuran at 20℃;93%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

tryptamine hydochloride
343-94-2

tryptamine hydochloride

methyl 2,3,5,6,11,11b-hexahydro-3-oxo-1H-indolizino<8,7-b>indole-11b-carboxylate
79888-13-4

methyl 2,3,5,6,11,11b-hexahydro-3-oxo-1H-indolizino<8,7-b>indole-11b-carboxylate

Conditions
ConditionsYield
In methanol for 20h; Heating;92%
In methanol Heating;92%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

ethyl 2-diethoxyphosphorylpropionate
3699-66-9

ethyl 2-diethoxyphosphorylpropionate

C12H18O6
496919-84-7

C12H18O6

Conditions
ConditionsYield
With hydrogen; sodium hydride In tetrahydrofuran at 0℃; Inert atmosphere;91%
With sodium hydride71%
With sodium hydride Horner-Wadsworth-Emmons Olefination;71%
9-aminothioxanthene 10,10-dioxide
17313-66-5

9-aminothioxanthene 10,10-dioxide

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

2-[(E)-10,10-Dioxo-9,10-dihydro-10λ6-thioxanthen-9-ylimino]-pentanedioic acid dimethyl ester

2-[(E)-10,10-Dioxo-9,10-dihydro-10λ6-thioxanthen-9-ylimino]-pentanedioic acid dimethyl ester

Conditions
ConditionsYield
With 4 A molecular sieve In toluene for 17h; Heating;86%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

propynoic acid methyl ester
922-67-8

propynoic acid methyl ester

methyl 4-((E)-2-(methoxycarbonyl)vinyloxy)-2-(2-(methoxycarbonyl)ethyl)-3-((methpxycarbonyl)methyl)-2,5-dihydro-5-oxofuran-2-carboxylate

methyl 4-((E)-2-(methoxycarbonyl)vinyloxy)-2-(2-(methoxycarbonyl)ethyl)-3-((methpxycarbonyl)methyl)-2,5-dihydro-5-oxofuran-2-carboxylate

Conditions
ConditionsYield
triethylamine In dichloromethane at 0℃;85%
With triethylamine In dichloromethane at 0℃;85%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

2-amino-6-(1-benzylhydrazinyl)pyrimidin-4(3H)-one
67873-25-0

2-amino-6-(1-benzylhydrazinyl)pyrimidin-4(3H)-one

methyl 3-(7-amino-1-benzyl-4,5-dioxo-1,4,5,6-tetrahydropyrimido[4,5-c]pyridazin-3-yl)propanoate
1374603-46-9

methyl 3-(7-amino-1-benzyl-4,5-dioxo-1,4,5,6-tetrahydropyrimido[4,5-c]pyridazin-3-yl)propanoate

Conditions
ConditionsYield
In water for 3h; Reflux;85%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

methyl 3-(3-oxo-3,4-dihydroquinoxalin-2-yl)propanoate
21580-64-3

methyl 3-(3-oxo-3,4-dihydroquinoxalin-2-yl)propanoate

Conditions
ConditionsYield
In methanol for 16h; Inert atmosphere;84%
In ethanol Reflux;
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

dimethyl (E)-2-oxoglutaconate
38256-25-6

dimethyl (E)-2-oxoglutaconate

Conditions
ConditionsYield
Stage #1: dimethyl 2-ketoglutarate With bromine In dichloromethane for 4.25h; Heating / reflux;
Stage #2: With triethylamine In diethyl ether at 35℃; for 0.75h;
83.1%
Stage #1: dimethyl 2-ketoglutarate With bromine In dichloromethane for 3h; Reflux; Inert atmosphere;
Stage #2: With triethylamine In diethyl ether at 20℃; for 0.5h;
70%
Stage #1: dimethyl 2-ketoglutarate With bromine In dichloromethane for 3h; Heating;
Stage #2: With triethylamine In diethyl ether for 0.5h; Further stages.;
3.6 mmol
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

ethyl 2-diethoxyphosphorylpropionate
3699-66-9

ethyl 2-diethoxyphosphorylpropionate

C13H22O5

C13H22O5

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran for 0.5h;82%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

ethyl 2-diethoxyphosphorylpropionate
3699-66-9

ethyl 2-diethoxyphosphorylpropionate

C12H18O6

C12H18O6

Conditions
ConditionsYield
Stage #1: ethyl 2-diethoxyphosphorylpropionate With sodium hydride In tetrahydrofuran for 0.5h;
Stage #2: dimethyl 2-ketoglutarate In tetrahydrofuran for 0.5h;
82%
ethanol
64-17-5

ethanol

dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

(2,4-difluorobenzyl)hydrazine
627076-28-2

(2,4-difluorobenzyl)hydrazine

A

methyl 1-(2,4-difluorobenzyl)-6-oxo-1,4,5,6-tetrahydro-pyridazine-3-carboxylate
1297284-15-1

methyl 1-(2,4-difluorobenzyl)-6-oxo-1,4,5,6-tetrahydro-pyridazine-3-carboxylate

B

ethyl 1-(2,4-difluorobenzyl)-6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxylate
1297284-16-2

ethyl 1-(2,4-difluorobenzyl)-6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxylate

Conditions
ConditionsYield
hydrogenchloride Reflux;A 82%
B 6.1%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

benzylamine
100-46-9

benzylamine

methyl 5-(benzylamino)-4,5-dioxopentanoate
1397970-85-2

methyl 5-(benzylamino)-4,5-dioxopentanoate

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 6h; Inert atmosphere;82%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

ethyl 2-diethoxyphosphorylpropionate
3699-66-9

ethyl 2-diethoxyphosphorylpropionate

C11H16O6

C11H16O6

Conditions
ConditionsYield
Stage #1: ethyl 2-diethoxyphosphorylpropionate With sodium hydride In tetrahydrofuran; mineral oil
Stage #2: dimethyl 2-ketoglutarate In tetrahydrofuran; mineral oil for 0.5h;
82%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

6-methoxytryptamine-2-carboxylic acid
20731-72-0

6-methoxytryptamine-2-carboxylic acid

methyl 9-methoxy-2,3,5,6,11,11b-hexahydro-3-oxo-1H-indolizino<8,7-b>indole-11b-carboxylate
129968-06-5

methyl 9-methoxy-2,3,5,6,11,11b-hexahydro-3-oxo-1H-indolizino<8,7-b>indole-11b-carboxylate

Conditions
ConditionsYield
With trifluoroacetic acid In 1,4-dioxane; benzene Heating;80%
With trifluoroacetic acid In 1,4-dioxane; benzene for 24h; Heating;80%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

ethyl 2-diethoxyphosphorylpropionate
3699-66-9

ethyl 2-diethoxyphosphorylpropionate

2-propionic-3-methylmaleic anhydride
487-66-1

2-propionic-3-methylmaleic anhydride

Conditions
ConditionsYield
Stage #1: dimethyl 2-ketoglutarate; ethyl 2-diethoxyphosphorylpropionate With sodium hydride In tetrahydrofuran for 0.5h;
Stage #2: With water; potassium hydroxide In ethanol for 1h; Reflux;
80%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

benzylhydrazine dihydrochloride
20570-96-1

benzylhydrazine dihydrochloride

methyl 1-benzyl-6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxylate
1297284-35-5

methyl 1-benzyl-6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxylate

Conditions
ConditionsYield
hydrogenchloride In ethanol for 15h; Inert atmosphere; Reflux;79%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

methyl 2-hydroxy-4-(metoxycarbonyl)butanoate
81077-10-3

methyl 2-hydroxy-4-(metoxycarbonyl)butanoate

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol at 0 - 20℃; for 24h; Inert atmosphere;78%
With sodium tetrahydroborate In methanol; dichloromethane for 0.5h; Ambient temperature;74%
With sodium tetrahydroborate65%
With sodium tetrahydroborate In methanol
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

di-isopropyl azodicarboxylate
2446-83-5

di-isopropyl azodicarboxylate

3-isopropyl 2-methyl 5-isopropoxy-2-(3-methoxy-3-oxopropyl)-1,3,4-oxadiazole-2,3(2H)-dicarboxylate

3-isopropyl 2-methyl 5-isopropoxy-2-(3-methoxy-3-oxopropyl)-1,3,4-oxadiazole-2,3(2H)-dicarboxylate

Conditions
ConditionsYield
With 9-phenyl-9-phosphafluorene; Bis(p-nitrophenyl) phosphate; phenylsilane; N-ethyl-N,N-diisopropylamine In toluene at 90℃; for 3.5h; Inert atmosphere;76%
dimethyl 2-ketoglutarate
13192-04-6

dimethyl 2-ketoglutarate

5-chloro-2-nitrophenylhydrazine
1966-16-1

5-chloro-2-nitrophenylhydrazine

dimethyl (E)-2-(5-chloro-2-nitrophenylhydrazono)glutarate
143263-49-4

dimethyl (E)-2-(5-chloro-2-nitrophenylhydrazono)glutarate

Conditions
ConditionsYield
With hydrogenchloride In methanol at 20℃; for 1h;75%

13192-04-6Relevant articles and documents

Novel 3-(2-Oxo-2H-benzo[b][1,4]oxazin-3-yl)propanoates from dimethyl-2-oxoglutarate and test of their biological activity

Hachama, Kamel,Khodja, Mohamed,Moulay, Saad,Boutoumi, Hocine,Hennig, Lothar,Sicker, Dieter

, p. 413 - 416 (2013)

Five novel 3-(2-oxo-2H-benzo[b][1,4]oxazin-3-yl)propanoates were synthesized under mild conditions from 2-aminophenols and dimethyl-2- oxoglutarate. Biological assays of these 1,4-benzoxazinones were conducted with three bacterial strains and one yeast. All compounds were active against a Candida albicans ATCC 10231, whereas only methyl 3-(6-methyl-2-oxo-2H-benzo[b] [1,4]oxazin-3-yl)propanoate showed a general moderate activity against the bacterial strains tested.

An efficient synthesis of 4-aryl kainic acid analogs

Maeda, Hiroshi,Selvakumar, Natesan,Kraus, George A.

, p. 943 - 954 (1999)

A synthesis of 4-aryl kainic acid analogs was achieved using a highly stereoselective Michael addition reaction of dimethyl 2-oxoglutarate with a nitrostyrene. Nitro group reduction, deoxygenation and epimerization complete the synthetic route.

Metabolic fate of depsides and alkaloid constituents in aqueous extracts from Mercurialis perennis L. during fermentation

Lorenz, Peter,Conrad, Juergen,Stintzing, Florian C.

, p. 1706 - 1723 (2013)

Dog's mercury (Mercurialis perennis L.) is an old medicinal plant, nowadays used in complementary medicine. Aqueous fermented extracts of the plant are being mainly applied in remedies to treat external inflammations, but a thorough phytochemical characterization is still lacking. Therefore, the conversion of characteristic compound classes from M. perennis extracts during fermentation and storage was investigated. The microbial transformation of the two main depsides phaselic acid (=(2R)-O-[(E)-caffeoyl]malic acid; 1) and mercurialis acid (=(2R)-[(E)-caffeoyloxy]glutaric acid; 2) was monitored by HPLC-DAD. The degradation followed a second-order kinetic, and the calculated half-life periods of both constituents were 67 and 30 months, respectively. Several depside metabolites were detected by GC/MS in AcOEt extracts as tBuMe2Si (TBDMS) derivatives after derivatization, mainly dihydrocinnamic acids. Moreover, numerous α-hydroxy acids were found, allegedly as degradation products from amino acids or peptides. The microbial alteration of the main alkaloid hermidin was also examined. After three days of fermentation, three novel N-metabolites were formed and thoroughly assigned in CH2Cl2 extracts as a mixture of 3-ethylhermidin, 3-ethylhermidin quinone, and (E/Z)-3-ethylidenehermidin by GC/MS and NMR methods, as well as by means of total synthesis. A mechanism for the formation of these N-metabolites starting from dimeric hermidin oxidation products is proposed. The obtained results reveal the complex pathways plant constituents may undergo during the fermentation of the extracts. Copyright

A Br?nsted acidic, ionic liquid containing, heteropolyacid functionalized polysiloxane network as a highly selective catalyst for the esterification of dicarboxylic acids

Rajabi, Fatemeh,Wilhelm, Christian,Thiel, Werner R.

supporting information, p. 4438 - 4444 (2020/08/10)

A Br?nsted acidic, ionic liquid containing, heteropolyanion functionalized polysiloxane network was formed by self-condensation of dodecatungstophosphoric acid and a zwitterionic organosilane precursor containing both imidazolinium and sulfonate groups. The resulting hybrid material POS-HPA-IL was investigated as a catalyst for the selective esterification of dicarboxylic acids.

Biotechnological properties of sponges from northeast Brazil: Cliona varians as a Biocatalyst for Enantioselective Reduction of Carbonyl Compounds

Riatto, Valéria B.,Victor, Mauricio M.,Sousa, Jaqueline F.,Menegola, Carla

, p. 149 - 157 (2018/12/13)

To research the potential ability of whole marine sponges to act as biocatalysts, this paper describes for the first time the employment of whole Cliona varians sponge in the stereoselective reduction of prochiral α-keto esters and isatin to the corresponding chiral alcohols. The addition of D-fructose, D-glucose or sucrose remarkably increased the conversion ratios and stereoselectivities by this marine sponge. Furthermore, in the presence of D-glucose and D-maltose, the reduction of isatin by C. varians afforded the corresponding 3-hydroxyindolin-2-one with high conversions (85-90percent) and good enantioselectivities (60-74percent). These results showed that the marine sponge presents great potential to be used as biocatalyst for stereoselective reduction of carbonyl compounds.

Identification and Structure-Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors

Ferreira De Freitas, Renato,Harding, Rachel J.,Franzoni, Ivan,Ravichandran, Mani,Mann, Mandeep K.,Ouyang, Hui,Lautens, Mark,Santhakumar, Vijayaratnam,Arrowsmith, Cheryl H.,Schapira, Matthieu

supporting information, p. 4517 - 4527 (2018/05/31)

HDAC6 plays a central role in the recruitment of protein aggregates for lysosomal degradation and is a promising target for combination therapy with proteasome inhibitors in multiple myeloma. Pharmacologically displacing ubiquitin from the zinc-finger ubiquitin-binding domain (ZnF-UBD) of HDAC6 is an underexplored alternative to catalytic inhibition. Here, we present the discovery of an HDAC6 ZnF-UBD-focused chemical series and its progression from virtual screening hits to low micromolar inhibitors. A carboxylate mimicking the C-terminal extremity of ubiquitin, and an extended aromatic system stacking with W1182 and R1155, are necessary for activity. One of the compounds induced a conformational remodeling of the binding site where the primary binding pocket opens up onto a ligand-able secondary pocket that may be exploited to increase potency. The preliminary structure-activity relationship accompanied by nine crystal structures should enable further optimization into a chemical probe to investigate the merit of targeting the ZnF-UBD of HDAC6 in multiple myeloma and other diseases.

Identification and quantification of aerosol polar oxygenated compounds bearing carboxylic or hydroxyl groups. 1. Method development

Jaoui,Kleindienst,Lewandowski,Edney

, p. 4765 - 4778 (2007/10/03)

In this study, a new analytical technique was developed for the identification and quantification of multifunctional compounds containing simultaneously at least one hydroxyl or one carboxylic group, or both. This technique is based on derivatizing first the carboxylic group(s) of the multifunctional compound using an alcohol (e.g., methanol, 1-butanol) in the presence of a relatively strong Lewis acid (BF3) as a catalyst. This esterification reaction quicldy and quantitatively converts carboxylic acids to their ester forms. The second step is based on silylation of the ester compounds using bis(trimethylsilyl) trifluoroacetamide (BSTFA) as the derivatizing agent. For compounds bearing ketone groups in addition to carboxylic and hydroxyl groups, a third step was used based on PFBHA derivatization of the carbonyls. Different parameters including temperature, reaction time, and effect due to artifacts were optimized. A GC/MS in EI and in methane-CI mode was used for the analysis of these compounds. The new approach was tested on a number of multifunctional compounds. The interpretation of their EI (70 eV) and CI mass spectra shows that critical information is gained leading to unambiguous identification of unknown compounds. For example, when derivatized only with BF3-methanol, their mass spectra comprise primary ions at m/z M .+ + 1, M.+ + 29, and M.- - 31 for compounds bearing only carboxylic groups and M.- + 1, M.+ + 29, M.+ - 31, and M+. - 17 for those bearing hydroxyl and carboxylic groups. However, when a second derivatization (BSTFA) was used, compounds bearing hydroxyl and carboxylic groups simultaneously show, in addition to the ions observed before, ions at m/z M.+ + 73, M .+ - 15, M.+ - 59, M.+ - 75, M.+ - 89, and 73. To the best of our knowledge, this technique describes systematically for the first time a method for identifying multifunctional oxygenated compounds containing simultaneously one or more hydroxyl and carboxylic acid groups.

Combination strategy using pure enzymes and whole cells as biocatalysts for the preparation of 2-hydroxyesters and lactones from 2-oxoglutaric acid

Rustoy, Eduardo M.,Pereyra, Elba N.,Moreno, Silvia,Baldessari, Alicia

, p. 3763 - 3768 (2007/10/03)

An innovative combination strategy that uses pure enzymes and whole microbial cells in the same process was used to prepare enantiomerically pure 3-carboxyalkyl-γ-butyrolactones and several alkyl esters of 2-hydroxyglutarate from 2-oxoglutaric acid. An innovative combination strategy that uses pure enzymes and whole microbial cells in the same process was used to prepare enantiomerically pure 3-carboxyalkyl-γ-butyrolactones and several alkyl esters of 2-hydroxyglutarates from 2-oxoglutaric acid. The method involves two consecutive biocatalytic steps. The first step, which converts the 2-oxoglutaric acid into the corresponding dialkyl esters, was catalyzed by a lipase. Then in the second step, by microbial reduction of the dialkyl-2-oxoglutarates, it is possible to obtain 3-carboxyalkyl-γ- butyrolactones or 2-hydroxyesters depending on the length of the chain in the alkyl moiety of the esters and on the fresh or lyophilized status of the cells.

Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport

Carrigan, Christina N.,Bartlett, Richard D.,Esslinger, C. Sean,Cybulski, Kimberly A.,Tongcharoensirikul, Pakamas,Bridges, Richard J.,Thompson, Charles M.

, p. 2260 - 2276 (2007/10/03)

The vesicular glutamate transport (VGLUT) system selectively mediates the uptake of L-glutamate into synaptic vesicles. Uptake is linked to an H+-ATPase that provides coupling among ATP hydrolysis, an electrochemical proton gradient, and glutamate transport. Substituted quinoline-2,4-dicarboxylic acids (QDCs), prepared by condensation of dimethyl ketoglutaconate (DKG) with substituted anilines and subsequent hydrolysis, were investigated as potential VGLUT inhibitors in synaptic vesicles. A brief panel of substituted QDCs was previously reported (Carrigan et al. Bioorg. Med. Chem. Lett. 1999, 9, 2607-2612)1 and showed that certain substituents led to more potent competitive inhibitors of VGLUT. Using these compounds as leads, an expanded series of QDC analogues were prepared either by condensation of DKG with novel anilines or via aryl-coupling (Suzuki or Heck) to dimethyl 6-bromoquinolinedicarboxylate. From the panel of almost 50 substituted QDCs tested as inhibitors of the VGLUT system, the 6-PhCH=CH-QDC (Ki = 167 μM), 6-PhCH2CH2-QDC (Ki = 143 μM), 6-(4′-phenylstyryl)-QDC (Ki = 64 μM), and 6-biphenyl-4-yl-QDC (Ki=41 μM) were found to be the most potent blockers. A preliminary assessment of the key elements needed for binding to the VGLUT protein based on the structure-activity relationships for the panel of substituted QDCs is discussed herein. The substituted QDCs represent the first synthetically derived VGLUT inhibitors and are promising templates for the development of selective transporter inhibitors.

Synthesis of the angiotensin-converting enzyme inhibitors (-)-A58365A and (-)-A58365B from a common intermediate

Clive, Derrick L. J.,Coltart, Don M.,Zhou, Yuanxi

, p. 1447 - 1454 (2007/10/03)

(-)-A58365A (1) and (-)-A58365B (2), which are inhibitors of angiotensin-converting enzyme, were synthesized from the subunits 9 and 10. These were coupled, and the resulting individual amides 17a,b were converted by ozonolysis into aldehydes 18a,b, which underwent cyclodehydration to the enamides 19a,b. Treatment with a stannane served to generate the vinyl stannanes 20a,b, from which ketones 22a,b were produced by protodestannylation and ozonolysis. Base treatment and hydrogenolysis then afforded (-)-A58365A (1). The intermediates 17a,b were also converted into aldehydes 26a,b by hydroboration and oxidation, and a similar sequence to that used for (-)-A58365A was then applied in order to complete the first enantiospecific synthesis of the congener, (-)-A58365B (2).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13192-04-6